RCT: Bortezomib in newly diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.

Children’s Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: New study finds bortezomib improves survival in children with newly diagnosed T-cell lymphoblastic lymphoma – Children’s Hospital of Philadelphia